Thymosin beta-4 has no current marketing authorisation. RegeneRx Biopharmaceuticals has conducted Phase II and Phase III trials of RGN-259 for dry eye disease and neurotrophic keratopathy, with mix...
View full compound profile →Vendors stocking
3
across 2 countries
Total listings
5
5 in stock
Price range
£16.95–£34.95
Median price per mg
£8.00
Most common size
10mg
2 listings
Stock health
100%
3 vendors · 5 listings
2mg
1 listing
Avg price: £16.95
Avg per mg: £8.47
5mg
2 listings
Avg price: £33.98
Avg per mg: £6.79
10mg
2 listings
Avg price: £79.99
Avg per mg: £8.00
This compound is sold as a research chemical and is not approved for human use. Information on this page is compiled from publicly available vendor listings and is provided for informational purposes only. PeptideTrace does not sell peptides, does not facilitate transactions, and does not recommend any vendor. Always verify product quality independently.
Prices last updated: 15 May 2026
Data sourced from 3 vendor websites across 2 countries
